Chronic pain and depression in patients with rheumatoid arthritis: Results of five-year follow-up [Хроническая боль и депрессия у больных...
Лисицyна Т. А., Абрамкин А. А., Велтишчев Д. Y., Серавина О. Ф., Ковалевскайа О. Б., Зелтyн А. Е., Глухова С. И., Насонов Е. Л., Краснов В. Н.
Терапевтический архив
Т. 91, Вып. 5, С. 8-18
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.26442/00403660.2019.05.000207
Аннотация:
The aim of the study was to analyze the factors affecting chronic pain in pa-tients with rheumatoid arthritis (RA). Materials and methods. 128 patients with reliable diagnosis of RA [111 (86.7[%]) women and 17 (13.3[%]) men] were examined. The mean age of patients was 47.4±11.3 years, the median duration of the disease was 96 [48; 228] months. When included in the study in most patients, the activity of RA in DAS28 was moderate (n=56; 43.7[%]) or high (n=48; 37.5[%]). BPI (Brief Pain Inventory) scale was used to determine the severity of pain and its impact on various aspects of life. The anxiety-depressive spectrum disor-ders (ADDs) were diagnosed by psychiatrist during a semi-structured inter-view according to ICD-10 criteria in 123 (96.1[%]) patients. The severity of depression was determined by the Montgomery-Asberg depression rating scale, anxiety - by Hamilton anxiety scale. For the diagnosis of cognitive impairment used clinical and psychological techniques. Psychopharma-cotherapy (PPhT)
Ключевые слова:
Antidepressants; Anxiety and depressive disorders; Anxiolytics; Chronic pain; Inflammation; Rheumatoid arthritis
antirheumatic agent; adult; anxiety; chronic pain; classification; complication; depression; female; human; male; middle aged; rheumatoid arthritis; severity of illness index; Adult; Antirheumatic Agents; Anxiety; Arthritis, Rheumatoid; Chronic Pain; Depression; Female; Humans; Male; Middle Aged; Severity of Illness Index
Язык текста: Русский
ISSN: 2309-5342
Лисицyна Т. А.
Абрамкин А. А.
Велтишчев Д. Y. Д.Ю.
Серавина О. Ф.
Ковалевскайа О. Б.
Зелтyн А. Е.
Глухова С. И.
Насонов Е. Л. Евгений Львович 1948-
Краснов В. Н.
Lisitsyna T. A.
Abramkin A. A.
Veltishchev D. Y. D.Yu.
Seravina O. F.
Kovalevskaya O. B.
Zeltyn A. E.
Glukhova S. I.
Nasonov E. L. Evgenij L`vovich 1948-
Krasnov V. N.
Chronic pain and depression in patients with rheumatoid arthritis: Results of five-year follow-up [Хроническая боль и депрессия у больных ревматоидным артритом: результаты пятилетнего наблюдения]
Chronic pain and depression in patients with rheumatoid arthritis: Results of five-year follow-up [Хроническая боль и депрессия у больных...
Текст визуальный непосредственный
Терапевтический архив
Медицинское маркетинговое агентство "МедиаМедика"
Т. 91, Вып. 5 С. 8-18
2019
Статья
Antidepressants Anxiety and depressive disorders Anxiolytics Chronic pain Inflammation Rheumatoid arthritis
antirheumatic agent adult anxiety chronic pain classification complication depression female human male middle aged rheumatoid arthritis severity of illness index Adult Antirheumatic Agents Anxiety Arthritis, Rheumatoid Chronic Pain Depression Female Humans Male Middle Aged Severity of Illness Index
The aim of the study was to analyze the factors affecting chronic pain in pa-tients with rheumatoid arthritis (RA). Materials and methods. 128 patients with reliable diagnosis of RA [111 (86.7[%]) women and 17 (13.3[%]) men] were examined. The mean age of patients was 47.4±11.3 years, the median duration of the disease was 96 [48; 228] months. When included in the study in most patients, the activity of RA in DAS28 was moderate (n=56; 43.7[%]) or high (n=48; 37.5[%]). BPI (Brief Pain Inventory) scale was used to determine the severity of pain and its impact on various aspects of life. The anxiety-depressive spectrum disor-ders (ADDs) were diagnosed by psychiatrist during a semi-structured inter-view according to ICD-10 criteria in 123 (96.1[%]) patients. The severity of depression was determined by the Montgomery-Asberg depression rating scale, anxiety - by Hamilton anxiety scale. For the diagnosis of cognitive impairment used clinical and psychological techniques. Psychopharma-cotherapy (PPhT)